文献速递胃肠外科

同一手术团队机器人对比腹腔镜胃癌根治术的倾向性评分匹配分析

Short- and long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer by the same surgical team: a propensity score matching analysis.
PubMed 文献 · Surg Endosc · 2021-01-11

该研究纳入2014年10月至2019年9月期间1686例连续接受微创胃癌根治术的患者,按手术方式分为机器人胃癌根治术(RG)组与腹腔镜胃癌根治术(LG)组,经倾向性评分1:1匹配后比较短期与长期结局。主要结局为3年总生存(OS)与无复发生存(RFS),次要结局为术后短期指标。结果显示RG在淋巴结清扫数量、胰腺上区淋巴结数量及估计出血量方面优于LG,但手术时间更长、住院费用更高,且3年OS与RFS无统计学显著差异。

要点

  • RG组获取淋巴结数量及胰腺上区淋巴结数量显著多于LG组。
  • RG组估计出血量显著低于LG组,但手术时间更长、住院费用更高。
  • 匹配队列中两组3年OS与RFS无统计学显著差异。

核心结论

  • RG相比LG具有一定技术优势,尤其在进展期胃癌患者中更为明显,但RG并未改善长期肿瘤学结局。

研究设计与样本

  • 回顾性队列研究,纳入2014年10月至2019年9月共1686例连续接受微创胃癌根治术的患者,按手术方式分为RG组与LG组。
  • 采用基于年龄、性别、ASA评分、原发肿瘤部位、组织学类型、病理分期及新辅助化疗的倾向性评分以1:1比例进行匹配。

主要发现

  • 匹配后RG组获取淋巴结数量显著高于LG组(32.15 vs 30.82,P=0.040)。
  • 匹配后RG组获取胰腺上区淋巴结数量显著多于LG组(12.45 vs 11.61,P=0.028)。
  • 匹配后RG组估计出血量显著低于LG组(73.67 vs 98.08 ml,P<0.001)。
  • 匹配后RG组手术时间显著长于LG组(205.18 vs 185.27 min,P<0.001),住院费用显著高于LG组($13,607 vs $10,928,P<0.001)。
  • 匹配队列中两组3年OS无统计学显著差异(LG 80.3% vs RG 81.2%,log-rank P=0.648),3年RFS亦无统计学显著差异(LG 77.0% vs RG 76.6%,log-rank P=0.951)。

临床怎么用

  • RG可作为胃癌微创手术的技术选择之一,其在淋巴结清扫和出血控制方面具有优势。
  • 对于进展期胃癌患者,RG可能带来更多获益,但需权衡更长手术时间与更高住院费用。
  • RG不应以改善长期肿瘤学结局为主要目的进行选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Research on short-term outcomes and oncology results after robotic gastrectomy (RG) is still limited, especially from a single surgical team. The purpose of this study was to compare the short-term and long-term outcomes of robotic and laparoscopic gastrectomy (LG). METHODS: Between October 2014 and September 2019, 1686 consecutive patients who underwent MIS gastrectomy were enrolled. The patients were divided into RG and LG groups according to surgical type. Groups were matched at a 1:1 ratio using propensity scores based on the following variables: age, sex, ASA score, primary tumor location, histologic type, pathological stage, and neoadjuvant chemotherapy. The primary outcomes were 3-year overall survival (OS) and relapse-free survival (RFS). The secondary outcomes were postoperative short-term outcomes. RESULTS: Demographic and baseline characteristics were similar between the two groups after matching. Compared to the LG group, the RG group had a significantly higher retrieved lymph node (LN) number (32.15 vs 30.82, P = 0.040), more retrieved supra-pancreatic LNs (12.45 vs 11.61, P = 0.028), lower estimated blood loss (73.67 vs 98.08 ml, P < 0.001), but longer operation time (205.18 vs 185.27 min, P < 0.001) and higher hospitalization costs ($13,607 vs $10,928, P < 0.001) in the matched cohort. In the subgroup analysis, we observed that compared with LG, patients with advanced gastric cancer benefitted more from RG surgery. The matched cohort analysis demonstrated no statistically significant differences for 3-year OS or RFS (log-rank, P = 0.648 and P = 0.951, respectively): 80.3% and 77.0% in LG vs. 81.2% and 76.6% in RG, respectively. CONCLUSION: RG has certain technical advantages over LG, especially in patients with advanced gastric cancer. However, RG does not improve long-term oncology outcomes.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tian Y, Cao S, Kong Y, et al. Short- and long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer by the same surgical team: a propensity score matching analysis. Surg Endosc. 2021. PMID: 33427913. doi:10.1007/s00464-020-08253-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。